Singapore HSA Updates Advertisement Guidance for Therapeutic Products

Singapore’s Health Sciences Authority (HSA) updated EXPLANATORY GUIDANCE TO THE HEALTH PRODUCTS (ADVERTISEMENT OF SPECIFIED HEALTH PRODUCTS) REGULATIONS for Therapeutic …

read more...

Vietnam MoH Issues Circular 41/2023/TT-BTC on Payment in Field of Pharmaceuticals and Cosmetics

On June 12, 2023, the Minister of Finance issued Circular 41/2023/TT-BTC on the rate, collection, payment, management and use in …

read more...

Singapore HSA Updates Therapeutic Product Registration Guidelines

As part of Singapore HSA’s ongoing initiatives to improve regulatory efficiency and enhance clarity in HSA’s regulatory requirements and processes, …

read more...

Singapore HSA Revises Guideline on Consignment Importation of Therapeutic Product

Singapore HSA revised Guideline on Import a Therapeutic Product on Consignment Basis. The revised guideline provides further clarity to the …

read more...

Singapore HSA Updates Guidance on Unregistered Therapeutic Product Import and Supply

In March 2023, HSA updated Guidance on Import and Supply of An Unregistered Therapeutic Product For Patients’ Use. See Pharma …

read more...

Singapore HSA Updates Unregistered Therapeutic Product Import and Supply Guidance and Forms

Singapore HSA Updates Guidance TPB-GN-004-005 regarding the Import and Supply of an Unregistered Therapeutic Product For Patients’ Use. HSA includes …

read more...

Singapore HSA Shares Statistic on HSA’s Mean Screening Time and Applicant’s Mean Screening Response Time For New Application and Major variation Applications

HSA strives to complete the screening of the new and major variation applications in the shortest possible time. For the …

read more...

Access Generic Medicines Work-Sharing Initiative

The Therapeutic Goods Administration (TGA) Australia has released further information on the Generic Medicines Work-Sharing Initiative. It is an innovative …

read more...

China NMPA Extends Drug Submission Time for Supplementing Materials

On October 14th, China’s National Medical Products Administration (NMPA) announced an extra 80 to 160 days extension for the submission …

read more...

More News